Brandon Bravo

Brandon Bravo possesses extensive experience in the biotechnology and pharmaceutical industries, currently serving as a Senior Scientist at Nurix Therapeutics since August 2018, following ascending roles as Scientist II and Scientist. Prior experience includes a position as Senior Associate Scientist at Amgen from October 2015 to July 2018 and a Research Associate II role at Genentech from December 2008 to October 2015, contributing to the Biochemical Pharmacology Department. Brandon began career experience at Roche Pharmaceuticals as a Research Associate in 2008. Educational qualifications include a Master of Science in Molecular Biology from San Francisco State University and a Bachelor of Arts in Biology from UC Santa Barbara.